Open

Multiple Sclerosis Drug Study

In this study, we want to compare a new drug for multiple sclerosis (MS) with a drug that is already being used. We want to see how the new drug works and if it might be a better option for treating MS.

Age & Gender

18 years ~ 55 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)
Visits can be combined with regular clinical appointments

Location

United States (Nationwide)

What will be asked of you

At each visit, you will meet with a member of the study team and fill out questionnaires. The study also involves blood draws, assessments, and willingness to receive study treatment.

Incentives

You will be reimbursed according to the following schedule: $100.00 per study visit, except Visits M1, M6, and M12, for which you will be reimbursed $150.00. , travel reimbursement

In-person visits:
28

Phone or online visits:
28

Total length of participation:
about 7.5 years

Looking for Specific Volunteers

Able to participate:

You have been diagnosed with RMS, including relapsing-remitting MS (RRMS) or secondary progressive MS (SPMS)
You have had one documented relapse within the previous year
You have had two documented relapses within the previous two years
You have had one active Gadolinium (Gd)-enhancing lesion in the previous year

Not eligible if:

You have been diagnosed with primary progressive MS (PPMS)
You have had a stroke, traumatic brain or spinal injury, or myelopathy
You are pregnant or nursing

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Irena Dujmovic Basuroski, MD
irdujm@neurology.unc.edu
(984) 974-4401

Primary Visit Location

Adult Neurology Outpatient Clinic
UNC Meadowmont
300 Meadowmont Village Cir, Chapel Hill, NC 27517, USA

Additional Study Information

Principal Investigator

Irena Dujmovic Basuroski
Neurology

Study Type

Clinical or Medical
Interventional

Study Topics

Brain, Head, Nervous System

IRB Number

23-2366

ClinicalTrials.gov

NCT05156281

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.